Abstract:Dongxing Zhao, 1, 2 Asghar Abbasi, 1 Richard Casaburi, 1 Alessandra Adami, 3 Nicholas B Tiller, 1 Wei Yuan, 1, 4 Christopher Yee, 5 Nicholas G Jendzjowsky, 1 David M MacDonald, 6, 7 Ken M Kunisaki, 6, 7 William W Stringer, 1 Janos Porszasz, 1 Barry J Make, 8 Russell P Bowler, 8 Harry B Rossiter 1 On behalf of the COPDGene Investigators 1 Rehabilitation Clinical Trials Center, Division of Respiratory and Critical Care Physiology and Medicine, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA; 2 State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, People's Republic of China; 3 Department of Kinesiology, University of Rhode Island, Kingston, RI, USA; 4 Respiratory Medicine Department, Beijing Friendship Hospital Affiliated of Capital Medical University, Beijing, 100050, People's Republic of China; 5 MemorialCare Long Beach Medical Center, Long Beach, CA, USA; 6 Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Minnesota, Minneapolis, MN, USA; 7 Minneapolis VA Health Care System, Minneapolis, MN, USA; 8 National Jewish Health, Denver, CO, USA Correspondence: Harry B Rossiter Email Background: Slow heart rate recovery (HRR) after exercise is associated with autonomic dysfunction and increased mortality. What HRR criterion at 1-minute after a 6-minute walk test (6MWT) best defines pulmonary impairment?. Study Design and Methods: A total of 5008 phase 2 COPDGene (NCT00608764) participants with smoking history were included. A total of 2127 had COPD and, of these, 385 were followed-up 5-years later. Lung surgery, transplant, bronchiectasis, atrial fibrillation, heart failure and pacemakers were exclusionary. HR was measured from pulse oximetry at end-walk and after 1-min seated recovery. A receiver operator characteristic (ROC) identified optimal HRR cut-off. Generalized linear regression determined HRR association with spirometry, chest CT, symptoms and exacerbations. Results: HRR after 6MWT (bt/min) was categorized in quintiles: ≤ 5 (23.0% of participants), 6– 10 (20.7%), 11– 15 (18.9%), 16– 22 (18.5%) and ≥ 23 (18.9%). Compared to HRR≤ 5, HRR≥ 11 was associated with (p< 0.001): lower pre-walk HR and 1-min post HR; greater end-walk HR; greater 6MWD; greater FEV 1 %pred; lower airway wall area and wall thickness. HRR was positively associated with FEV 1 %pred and negatively associated with airway wall thickness. An optimal HRR ≤ 10 bt/min yielded an area under the ROC curve of 0.62 (95% CI 0.58– 0.66) for identifying FEV 1 < 30%pred. HRR≥ 11 bt/min was the lowest HRR associated with consistently less impairment in 6MWT, spirometry and CT variables. In COPD, HRR≤ 10 bt/min was associated with (p< 0.001): ≥ 2 exacerbations in the previous year (OR=1.76[1.33– 2.34]); CAT≥ 10 (OR=1.42[1.18– 1.71]); mMRC≥ 2 (OR=1.42[1.19– 1.69]); GOLD 4 (OR=1.98[1.44– 2.73]) and GOLD D (OR=1.51[1.18– 1.95]). HRR≤ 10 bt/min was predicted COPD exacerbations at 5-year follow-up (RR=1.83[1.07– 3.12], P=0.027). Conclusion: HRR≤ 10 bt/min after 6MWT in COPD is associated with more severe expiratory flow limitation, airway wall thickening, worse dyspnoea and quality of life, and future exacerbations, suggesting that an abnormal HRR≤ 10 bt/min after a 6MWT may be used in a comprehensive assessment in COPD for risk of severity, symptoms and future exacerbations. Keywords: autonomic dysfunction, chest computed tomography, COPD exacerbation, exercise, spirometry Chronic obstructive pulmonary disease (COPD) is associated with autonomic dysfunction 1,2 that predicts increased mortality. 3,4 Heart rate recovery (HRR) after exercise is an easily-acquired measure of autonomic dysfunction. 5 Abnormal HRR after maximal exercise, such as a cardiopulmonary exercise test (CPET), predicts overall mortality in various populations, 5–7 and associates with pulmonary function abnormalities. 8 In addition, in COPD, prevalence of impaired HRR increases with greater GOLD-defined severity of expiratory flow limitation. 9 The 6-minute walk test (6MWT) is a simple test of functional performance that is used widely in COPD patient assessment. Six-minute walk distance (6MWD) associates negatively with COPD hospitalizations, exacerbations and mortality 10 -Abstract Truncated-

Six-Minute Walk Test As A Predictor of Diagnosis, Disease Severity, and Clinical Outcomes in Scleroderma-Associated Pulmonary Hypertension: the Dibosa Study

VARIABILITY OF 6-MINUTE WALK DISTANCE IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS

Use of 6-Minute Walk Test for Assessing Severity of Interstitial Lung Disease: an Observational Study.

Application of six-minute walk test in patients receiving long-term hemodialysis with pulmonary hypertension

Features and predictive value of 6-min walk test outcomes in interstitial lung disease: an observation study using wearable monitors

Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease

Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis

Percent Predicted vs. Absolute Six-Minute Walk Distance as Predictors of Lung Transplant-Free Survival in Fibrosing Interstitial Lung Diseases

App-Based Versus Standard Six-Minute Walk Test in Pulmonary Hypertension: Mixed Methods Study

Prediction of Poor Short-Term Prognosis and Unmet Needs in Advanced Chronic Obstructive Pulmonary Disease: Use of the Two-Minute Walking Distance Extracted from a Six-Minute Walk Test

Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study

Six‐minute Walk Test Predicts All‐cause Mortality and Technique Failure in Ambulatory Peritoneal Dialysis Patients

Oxygen saturation recovery after 6-minute walk test in patients with idiopathic pulmonary fibrosis

Heart Rate Response Predicts 6-Minutes Walking Distance in Pulmonary Arterial Hypertension

Identifying a Heart Rate Recovery Criterion After a 6-Minute Walk Test in COPD

Incremental prognostic value of functional impairment assessed by 6-min walking test for the prediction of mortality in heart failure

Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery Pressure

0834 Association of Sleep Disordered Breathing and Hemodynamics of World Symposium on Pulmonary Hypertension Groups in PVDOMICS Cohort

Exercise-induced desaturation during a six-minute walk test is associated with poor clinical outcomes in patients with pulmonary arterial hypertension

Combination of echocardiography and pulmonary function tests could predict no complication of pulmonary hypertension during 5 years in patients with systemic sclerosis

Use of 6-min walk distance to predict lung transplant-free survival in fibrosing non-IPF interstitial lung diseases